Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

18.97

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.69

EPS Last/This Y

1.04

EPS This/Next Y

0.43

Price

0.67

Target Price

7

Analyst Recom

1

Performance Q

-34.15

Relative Volume

0.41

Beta

1.4

Ticker: MBRX



21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04MBRX0.34N/AN/A0
2025-07-07MBRX0.38N/AN/A0
2025-07-08MBRX0.5214N/AN/A0
2025-07-09MBRX0.5859N/AN/A0
2025-07-10MBRX0.5439N/AN/A0
2025-07-11MBRX0.5539N/AN/A0
2025-07-14MBRX0.6385N/AN/A0
2025-07-15MBRX0.6365N/AN/A0
2025-07-16MBRX0.6336N/AN/A0
2025-07-17MBRX0.8258N/AN/A0
2025-07-18MBRX0.802N/AN/A0
2025-07-21MBRX0.7997N/AN/A0
2025-07-22MBRX0.7732N/AN/A0
2025-07-23MBRX0.7024N/AN/A0
2025-07-24MBRX0.6303N/AN/A0
2025-07-25MBRX0.5615N/AN/A0
2025-07-28MBRX0.5502N/AN/A0
2025-07-29MBRX0.7164N/AN/A0
2025-07-30MBRX0.7N/AN/A0
2025-07-31MBRX0.6203N/AN/A0
2025-08-01MBRX0.6667N/AN/A0
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1



21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04MBRX0.34- - -5.28
2025-07-07MBRX0.38- - -5.28
2025-07-08MBRX0.52- - -5.28
2025-07-09MBRX0.57- -200.5-5.28
2025-07-10MBRX0.53- -0.2-5.28
2025-07-11MBRX0.55- -1.3-5.28
2025-07-14MBRX0.63- -17.7-5.28
2025-07-15MBRX0.63- -7.4-5.28
2025-07-16MBRX0.64- -8.5-5.28
2025-07-17MBRX0.84- -25.1-5.28
2025-07-18MBRX0.81- -5.9-5.28
2025-07-21MBRX0.80- -7.3-5.28
2025-07-22MBRX0.78- -6.1-5.28
2025-07-23MBRX0.71- -2.8-5.28
2025-07-24MBRX0.64- -1.9-5.28
2025-07-25MBRX0.57- -1.5-5.28
2025-07-28MBRX0.55- -6.2-5.28
2025-07-29MBRX0.71- -22.8-5.28
2025-07-30MBRX0.71- -5.9-5.28
2025-07-31MBRX0.63- -1.0-5.28
2025-08-01MBRX0.67- -10.9-5.28
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1



21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04MBRX81.600.998.79
2025-07-07MBRX81.590.998.79
2025-07-08MBRX81.590.998.79
2025-07-09MBRX81.520.998.79
2025-07-10MBRX81.470.998.79
2025-07-11MBRX81.580.9915.66
2025-07-14MBRX81.490.9915.66
2025-07-15MBRX81.490.9915.66
2025-07-16MBRX81.470.9915.66
2025-07-17MBRX55.840.9912.49
2025-07-18MBRX55.850.9912.49
2025-07-21MBRX55.820.9912.49
2025-07-22MBRX55.820.9912.49
2025-07-23MBRX55.830.9912.49
2025-07-24MBRX55.830.9912.49
2025-07-25MBRX55.850.9918.97
2025-07-28MBRX55.82202.9018.97
2025-07-29MBRX55.82202.9018.97
2025-07-30MBRX55.85202.9018.97
2025-07-31MBRX55.84202.9018.97
2025-08-01MBRX55.82202.9018.97
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

-0.69

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

55.82

Institutional Transactions

202.9

Beta

1.4

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

1

Growth Score

19

Sentiment Score

48

Actual DrawDown %

99.5

Max Drawdown 5-Year %

-99.7

Target Price

7

P/E

Forward P/E

PEG

P/S

P/B

223.94

P/Free Cash Flow

EPS

-5.8

Average EPS Est. Cur. Y​

-5.28

EPS Next Y. (Est.)

-4.85

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.41

Return on Equity vs Sector %

-55330.9

Return on Equity vs Industry %

-55312.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-10.9
Moleculin Biotech, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 17
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose for the treatment of pathogenic viruses and various cancers. The company was incorporated in 2015 and is headquartered in Houston, Texas.
stock quote shares MBRX – Moleculin Biotech Inc Stock Price stock today
news today MBRX – Moleculin Biotech Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MBRX – Moleculin Biotech Inc yahoo finance google finance
stock history MBRX – Moleculin Biotech Inc invest stock market
stock prices MBRX premarket after hours
ticker MBRX fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Facebook-f Twitter Tiktok Instagram Youtube

Get Started

About